EGFR and cancer: Several small molecule EGFR-tyrosine kinase inhibitors (TKIs) have been developed for the treatment of cancers overexpressing EGFRs including breast cancer, head and neck cancer, and non-small cell lung cancer [1,3,4,5,6].